15.08.2018 • Newschemical value chainPetrochemicalsSABIC

SABIC Partners with Design Firm on New Applications

SABIC partners with design firm Nottingham Spirk on new applications for its...
SABIC partners with design firm Nottingham Spirk on new applications for its specialty materials. © SABIC

Saudi petrochemicals and plastics group SABIC is working with US product design firm Nottingham Spirk to develop new uses for its specialty materials. With this partnership SABIC wants to leverage its ability to expand value for its customers while also contributing to Saudi Vision 2030.

In a statement, the Riyadh, Saudi Arabia-based group said: “This relationship brings together the benefits of SABIC's proprietary specialty thermoplastic offerings and Nottingham Spirk's award-winning capabilities to design and commercialize breakthrough products across multiple industrial verticals."

"SABIC's thermoplastics portfolio is renowned in many key industries such as automotive, aircraft and rail interiors, and electrical and electronics," noted Ernesto Occhiello, executive vice president of SABIC’s Specialties business unit. "Working closely with Nottingham Spirk and taking part in their proven innovation process enables us to look at the entire value chain differently for fresh creative ideas that support our customers’ growth aspirations," he added.

John Spirk, co-president of Cleveland-based Nottingham Spirk, said that the more his firm learned about the capabilities of SABIC's advanced plastics portfolio, the more inspired it was to start the collaboration. "The combination of SABIC's diverse portfolio of material solutions, along with our expertise in designing novel products that fill unmet end-user needs, create an infinite number of exciting possibilities for business innovation," Spirk said.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.